Skip to main content

Table 1 Distribution of low and high SRAP cases in case subgroups

From: Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients

Case subgroups

Low SRAP

High SRAP

Total

Pvalue

 

n (%)

n (%)

  

ER -

72 (71)

29 (29)

101

< 0.0001

ER+

115 (42)

156 (58)

271

 

PR -

78 (67)

37 (33)

115

0.0053

PR+

112(44)

145 (56)

257

 

Node -

95 (55)

80 (45)

172

0.2545

Node +

95 (48)

102 (52)

200

 

Low (3-5)

30 (39)

47 (61)

77

< 0.0001

Med (6-7)

97 (47)

109 (53)

206

 

High (8-9)

63 (71)

26 (29)

89

 

Low size (≤ 2.5 cm)

105 (54)

90 (46)

195

0.2992

High size (> 2.5 cm)

85 (48)

92 (52)

177

 

Age ≤ 64

113 (60)

77 (40)

190

0.0013

Age > 64

77 (42)

105 (58)

182

 

Total

190

182

372

 
  1. P-values correspond to Fisher's exact test. ER = estrogen receptor; PR = progesterone receptor; SRAP = steroid receptor RNA activator protein; + = positive; - = negative.